SlideShare uma empresa Scribd logo
1 de 24
ANTIFUNGAL THERAPY
   Tinea Infection Treatment
              By
     SUDIPTO HALDAR
Cause Of Fungal Infection

Superficial Fungal Infections may be caused by different
types of Fungi, like -
 Dermatophytes

 Molds

 Yeasts

The most common fungal infections are caused by the
Dermatophytes, which are the most abundant in their
distribution
Such infections are commonly termed as TINEA Infections
Tinea Infection:
 The common TINEA Infections are :
 Tinea corporis
 Tinea cruris
 Tinea pedis
 Tinea capitis
 Tinea versicolor
 Tinea unguium (Onychomycosis caused by dermatophytes)
 Common Superficial infections caused by oher species
 include
 Onychomycosis (caused by Candida)
 Cutaneous candidiasis
Tinea Corporis
   Cause: Tinea corporis is a common skin disorder among children.
    However, it may occur in people of all ages. It is caused by mold-like
    fungi called dermatophytes.
   Fungi thrive in warm, moist areas. The following raise your risk for a
    fungal infection:
   Long-term wetness of the skin (such as from sweating)
   Minor skin and nail injuries
   Poor hygiene
   Tinea corporis can spread easily to other people. You can catch the
    condition if you come into direct contact with an area of ringworm on
    someone's body, or if you touch contaminated items such as:
   Clothing
   Combs
   Pool surfaces
   Shower floors and walls
   The fungi can also be spread by pets (cats are common carriers).
Tinea Corporis

    Symptoms
     Symptoms may include itching.
     The rash begins as a small area of red, raised spots and
    pimples. The rash slowly becomes ring-shaped, with a red-
    colored, raised border and a clearer center. The border may
    look scaly.
    The rash may occur on the arms, legs, face, or other exposed
    body areas.
Tinea Corporis
Signs and tests
   The health care provider can often diagnose tinea corporis by
    how the skin looks.
   In some cases, the following tests may be done:
   Looking at a skin scraping of the rash under the microscope
    using a KOH (potassium hydroxide) test
   Skin lesion biopsy
Treatment
   TOPICAL THERAPY: Topical therapy should be applied to the
    lesion and at least 2 cm beyond this area once or twice a day for at least 2
    weeks, depending on which agent is used. Topical azoles and allylamines
    show high rates of clinical efficacy. These agents inhibit the synthesis of
    ergosterol, a major fungal cell membrane sterol.

   SYSTEMIC THERAPY: Systemic therapy may be indicated for
    tinea corporis that includes extensive skin infection, immunosuppression,
    resistance to topical antifungal therapy. Use of oral agents requires
    attention to potential drug interactions and monitoring for adverse effects.
Tinea Cruris
   Tinea cruris, a pruritic superficial fungal infection of the groin
    and adjacent skin, is the second most common clinical
    presentation for dermatophytosis. Tinea cruris is a common
    and important clinical problem that may, at times, be a
    diagnostic and therapeutic challenge.
PATHOPHYSIOLOGY

   The most common etiologic agents for tinea cruris
    include Trichophyton rubrum and Epidermophyton floccosum;
    less commonly Trichophyton mentagrophytes and
    Trichophyton verrucosum are involved.
   Tinea cruris is a contagious infection transmitted by fomites,
    such as contaminated towels or hotel bedroom sheets, or by
    autoinoculation from a reservoir on the hands or feet (tinea
    manuum, tinea pedis, tinea unguium).
   The etiologic agents in tinea cruris produce keratinases, which
    allow invasion of the cornified cell layer of the epidermis. The
    host immune response may prevent deeper invasion. Risk
    factors for initial tinea cruris infection or reinfection include
    wearing tight-fitting or wet clothing or undergarments.
Tinea Cruris Treatment
   Clinical cure of an uncomplicated tinea cruris infection usually can be
    achieved using topical antifungal agents of the imidazole or allylamine
    family. Consider patients unable to use topical treatments consistently or
    with extensive or recalcitrant infection as candidates for systemic
    administration of antifungal therapy, which has been proven safe in
    immunocompetent persons.
   Prevention of tinea cruris reinfection is an essential component of disease
    management. Patients with tinea cruris often have concurrent dermatophyte
    infections of the feet and hands.
   Treat all active areas of tinea cruris infection simultaneously to prevent
    reinfection of the groin from other body sites.
   Advise patients with tinea pedis to put on their socks before their
    undershorts to reduce the possibility of direct contamination.
   Advise patients with tinea cruris to dry the crural folds completely after
    bathing and to use separate towels for drying the groin and other parts of
    the body.
Tinea Pedis

 Tinea pedis is the term used for a dermatophyte infection of the soles of
the feet and the interdigital spaces. Tinea pedis is most commonly caused
byTrichophyton rubrum, a dermatophyte initially endemic only to a small
region of Southeast Asia and in parts of Africa and Australia. Interestingly,
tinea pedis was not noted in these areas then, possibly because these
populations did not wear occlusive footwear. The colonization of the T
rubrum –endemic regions by European nations helped to spread the fungus
throughout Europe. Wars with accompanying mass movements of troops
and refugees, the general increase in available means of travel, and the rise
in the use of occlusive footwear have all combined to make T rubrum the
world's most prevalent dermatophyte
Tinea Pedis
  Causes:
   Athlete's foot occurs when a certain fungus grows on your skin in your
   feet. In addition to the toes, it may also occur on the heels, palms, and
   between the fingers.
 Athlete's foot is the most common type of tinea fungal infections. The
   fungus thrives in warm, moist areas. Your risk for getting athlete's foot
   increases if you:
 Wear closed shoes, especially if they are plastic-lined

 Keep your feet wet for prolonged periods of time

 Sweat a lot

 Develop a minor skin or nail injury

 Athlete's foot is contagious, and can be passed through direct contact, or
   contact with items such as shoes, stockings, and shower or pool surfaces.
Symptoms
   The most common symptom is cracked, flaking, peeling skin
    between the toes or side of the foot. Other symptoms can
    include:
   Red and itchy skin
   Burning or stinging pain
   Blisters that ooze or get crusty
   If the fungus spreads to your nails, they can become
    discolored, thick, and even crumble.
   Athlete's foot may occur at the same time as other fungal skin
    infections such as ringworm or jock itch.
Tinea Pedis Treatment
   Tinea pedis can be treated with topical or oral antifungals or a combination
    of both. Topical agents are used for 1-6 weeks, depending on
    manufacturers' recommendations. A patient with chronic hyperkeratotic
    (moccasin) tinea pedis should be instructed to apply medication to the
    bottoms and sides of his or her feet. For interdigital tinea pedis, even
    though symptoms may not be present, a patient should apply the topical
    agent to the interdigital areas and to the soles because of the likelihood of
    plantar-surface infection.
Tinea Versicolor

   A fungal infection of the skin caused by Malassezia furfur and
    characterized by finely desquamating, pale tan patches on the
    upper trunk and upper arms that may itch and do not tan. In
    dark-skinned people the lesions may be depigmented. The
    fungus fluoresces under Wood's light and may be easily
    identified in scrapings viewed under a microscope. Topical
    and oral antifungal agents may be used, as well as repeated
    applications of selenium sulfide. The pale patches may persist
    for up to 1 year after successful treatment, and recurrence is
    common.
Tinea Versicolor

   Signs & Symptoms: Acidic bleach from the growing yeast
    causes areas of skin to be a different color than the skin around
    them. These can be individual spots or patches. Specific signs
    and symptoms of the infection include:
   Patches that may be white, pink, red, or brown and can be
    lighter or darker than the skin around them.
   Spots that do not tan the way the rest of your skin does.
   Spots that may occur anywhere on your body but are most
    commonly seen on your neck, chest, back, and arms.
   The spots may disappear during cool weather and get worse
    during warm and humid weather. They may be dry and scaly
    and may itch or hurt, although this is not common.
Treatment Of Tinea Versicolor
   Treatment of tinea versicolor can consist of creams, lotions, or
    shampoos that are put on the skin. It can also include
    medication given as pills. The type of treatment will depend
    on the size, location, and thickness of the infected area.
     Treatment options include:

   Topical anti-fungals:These products are applied directly to
    your skin and may be in the form of lotions, shampoos,
    creams, or soaps. They keep the growth of the yeast under
    control. Over-the-counter anti-fungal topical products
    containing ingredients such as selenium sulfide, miconazole,
    clotrimazole, and terbinafine are available. But sometimes
    prescription medications may be needed.
Treatment Of Tinea Versicolor

    Anti-fungal pills: These may be used to treat more serious or
     recurrent cases of tinea versicolor. Or in some cases they may
     be used because they can provide a simpler and quicker
     resolution of the infection. These medicines are given by
     prescription and can have side effects. So it's important to be
     monitored by your doctor while using anti-fungal pills.
    Treatment usually eliminates the fungal infection. However, the
     discoloration of the skin may take up to several months to
     resolve.
Onychomycosis

   Onychomycosis is a fungal infection of the toenails or
    fingernails.
   Cause: Onychomycosis causes fingernails or toenails to
    thicken, discolor, disfigure, and split. At first, onychomycosis
    appears to be only a cosmetic concern. Without treatment,
    however, the toenails can become so thick that they press
    against the inside of the shoes, causing pressure, irritation,
    and pain. Fingernail infection may cause psychological, social,
    or employment-related problems.
Onychomycosis Symptoms & Signs
   Onychomycosis usually does not cause any symptoms unless
    the nail becomes so thick it causes pain when wearing shoes.
    People with onychomycosis usually go to the doctor for
    cosmetic reasons, not because of physical pain or problems
    related to onychomycosis.
   As the nail thickens, onychomycosis may interfere with
    standing, walking, and exercising.
   Paresthesia (a sensation of pricking, tingling, or creeping on
    the skin having noobjective cause and usually associated
    with injury or irritation of a nerve), pain, discomfort, and loss
    of agility (dexterity) may occur. Loss of self-esteem,
    embarrassment, and social problems can also develop.
   Severe cases of Candida infections can disfigure the fingertips
    and nails.
Treatment on Onychomycosis

   In the past, medicines used to treat onychomycosis (OM) were
    not very effective. OM is difficult to treat because nails grow
    slowly and receive very little blood supply. However, recent
    advances in treatment options, including oral (taken by mouth)
    and topical (applied on the skin or nail surface) medications,
    have been made. Newer oral medicines have revolutionized
    treatment of onychomycosis. However, the rate of
    recurrence is high, even with newer medicines. Treatment is
    expensive, has certain risks, and recurrence is possible.
Dosage & Administration Of Terbinafine to
               Eradicate Tinea
   The Oral dose of Terbinafine is a constant 250 mg O.D. in adults
   The duration can vary considerably, depending on the condition (severity,
    area of distribution and duration of the disease)
   ADULT DOSAGE
   Tinea Corporis : Topical application once or twice daily, for 1 to 2 wks;
                             Orally 250 mg O.D. for up to 4 weeks

   Tinea Cruris : Topical application once or twice daily for 1 to 2 weeks;
                          Orally 250 mg O.D. for 2 to 4 weeks

   Tinea Pedis : Topical application once or twice daily for 1 week;
                 Orally 250 mg O.D. for up to 6 weeks

   Tinea Capitis : Orally 250 mg O.D. for 4 weeks (rarely found in adults)
   Tinea Versicolor : Topical application once or twice daily for 1 to 2
    weeks, suitable oral antimycotic drug may be co-prescribed, like
    Terbinafine itself, or Fluconazole.
Dosage & Administration Of Terbinafine
   PAEDIATRIC DOSAGE
   Terbinafine can be safely used in children over 1 year of age, for Tinea infections,
    Onychomycosis, and especially Tinea Capitis, in the following per kg body wt.
    dose:

   10 - 20 kg      -         62.5 mg O.D.
   20 - 40 kg      -         125 mg O.D.
   >40 kg                    -        250 mg O.D.

   The indication-wise dosage in children is as follows :
         Tinea Capitis      -          2 weeks to 4 weeks
         Tinea Cruris       -          2 to 4 weeks
         Tinea Corporis - 4 weeks
         Onychomycosis - Up to 6 weeks, in case of fingernail, or
                             longer
                             Up to 12 weeks, in case of toenail, or
                             longer
Adjuvant therapy with Ketoconazole in Tinea
                 Infection
2% Ketoconazole w/w offers freedom from and protects against
 Tinea Versicolor, and also effective as an adjuvant therapy
 along with topical and oral antifungal drugs to treat tinea and
 candida skin infections.

Mais conteúdo relacionado

Mais procurados (20)

Tinea Capitis
Tinea CapitisTinea Capitis
Tinea Capitis
 
Superficial Fungal Infections
Superficial  Fungal InfectionsSuperficial  Fungal Infections
Superficial Fungal Infections
 
Dermatology made easy
Dermatology made easyDermatology made easy
Dermatology made easy
 
Bacterial infection of the skin
Bacterial infection of the skin Bacterial infection of the skin
Bacterial infection of the skin
 
Tinea versicolor
Tinea versicolorTinea versicolor
Tinea versicolor
 
Fungal infections prenav
Fungal infections prenavFungal infections prenav
Fungal infections prenav
 
Scabies
ScabiesScabies
Scabies
 
Skin disorders pp
Skin disorders ppSkin disorders pp
Skin disorders pp
 
Fungal infections
Fungal infectionsFungal infections
Fungal infections
 
Pruritis or itching
Pruritis or itchingPruritis or itching
Pruritis or itching
 
Ecthyma
EcthymaEcthyma
Ecthyma
 
fungal infection of skin ppt
fungal infection of skin ppt fungal infection of skin ppt
fungal infection of skin ppt
 
Atopic dermatitis
Atopic dermatitisAtopic dermatitis
Atopic dermatitis
 
Atopic dermatitis
Atopic dermatitisAtopic dermatitis
Atopic dermatitis
 
Atopic dermatitis
Atopic dermatitisAtopic dermatitis
Atopic dermatitis
 
Bacterial skin infection- dermatology
Bacterial skin infection- dermatologyBacterial skin infection- dermatology
Bacterial skin infection- dermatology
 
Dermatology osce slides
Dermatology osce slidesDermatology osce slides
Dermatology osce slides
 
Urticaria
UrticariaUrticaria
Urticaria
 
Skin infections
Skin infectionsSkin infections
Skin infections
 
Pediatric Dermatology
Pediatric DermatologyPediatric Dermatology
Pediatric Dermatology
 

Destaque (16)

CCDM, Control of Communicable Diseases in Man
CCDM, Control of Communicable Diseases in ManCCDM, Control of Communicable Diseases in Man
CCDM, Control of Communicable Diseases in Man
 
Vertigo 2010
Vertigo 2010Vertigo 2010
Vertigo 2010
 
Benign Paroxysmal Positional Vertigo (BPPV)
Benign Paroxysmal Positional Vertigo (BPPV)Benign Paroxysmal Positional Vertigo (BPPV)
Benign Paroxysmal Positional Vertigo (BPPV)
 
Bppv 16 06-2015
Bppv 16 06-2015Bppv 16 06-2015
Bppv 16 06-2015
 
Bppv and particle repositioning maneuvers
Bppv and particle repositioning maneuversBppv and particle repositioning maneuvers
Bppv and particle repositioning maneuvers
 
Ndikimi i mjedisit ne trupin e njeriut
Ndikimi i mjedisit ne trupin e njeriutNdikimi i mjedisit ne trupin e njeriut
Ndikimi i mjedisit ne trupin e njeriut
 
4 h fungal diseases
4 h fungal diseases4 h fungal diseases
4 h fungal diseases
 
Stresi dhe Trauma
Stresi dhe TraumaStresi dhe Trauma
Stresi dhe Trauma
 
Parasitic and mycotic diseases
Parasitic and mycotic diseasesParasitic and mycotic diseases
Parasitic and mycotic diseases
 
Fungal infections2012
Fungal infections2012Fungal infections2012
Fungal infections2012
 
Nail shapes
Nail shapesNail shapes
Nail shapes
 
Nje ushqyerje e mire per nje trup dhe mendje te shendoshe
Nje ushqyerje e mire per nje trup dhe mendje te shendosheNje ushqyerje e mire per nje trup dhe mendje te shendoshe
Nje ushqyerje e mire per nje trup dhe mendje te shendoshe
 
innate immunity
innate immunityinnate immunity
innate immunity
 
Skin infection[1]
Skin infection[1]Skin infection[1]
Skin infection[1]
 
NJE USHQYERJE E MIRE PER NJE TRUP E MENDJE TE SHENDOSHE
NJE USHQYERJE E MIRE PER NJE TRUP E MENDJE TE SHENDOSHE NJE USHQYERJE E MIRE PER NJE TRUP E MENDJE TE SHENDOSHE
NJE USHQYERJE E MIRE PER NJE TRUP E MENDJE TE SHENDOSHE
 
Slideshare ppt
Slideshare pptSlideshare ppt
Slideshare ppt
 

Semelhante a Slides on fungal disease 2

Identification of patients with dermatophytes
Identification of patients with dermatophytes Identification of patients with dermatophytes
Identification of patients with dermatophytes Philipo Mwanjonde
 
Dermatophyte,_candida_and_aspergillosis.pdf
Dermatophyte,_candida_and_aspergillosis.pdfDermatophyte,_candida_and_aspergillosis.pdf
Dermatophyte,_candida_and_aspergillosis.pdfMidhatSarfraz
 
Fungal infection of skin (Dermatophytosis , yeast infection)
Fungal infection of skin (Dermatophytosis , yeast infection)Fungal infection of skin (Dermatophytosis , yeast infection)
Fungal infection of skin (Dermatophytosis , yeast infection)Hasnat Tariq
 
5. dermatological infections
5. dermatological infections5. dermatological infections
5. dermatological infectionsdthewitt
 
dermatological infections.pptx
dermatological infections.pptxdermatological infections.pptx
dermatological infections.pptxLubabahAbdulKarim
 
Dermatophyte infection (2).pptx
Dermatophyte infection (2).pptxDermatophyte infection (2).pptx
Dermatophyte infection (2).pptxhussainAltaher
 
Superficial fungal infections
Superficial fungal infectionsSuperficial fungal infections
Superficial fungal infectionsALEX PANICKER
 
Fungal Infections.pptx
Fungal Infections.pptxFungal Infections.pptx
Fungal Infections.pptxOsmanHassan35
 
Superficial fungal skin infections.ppt
Superficial fungal skin infections.pptSuperficial fungal skin infections.ppt
Superficial fungal skin infections.pptaliimad10
 
Common Dermatological Problems
Common Dermatological ProblemsCommon Dermatological Problems
Common Dermatological ProblemsMustafa AlWard
 

Semelhante a Slides on fungal disease 2 (20)

Fungal diseases in humans part 1
Fungal diseases in humans part 1Fungal diseases in humans part 1
Fungal diseases in humans part 1
 
ashe.s.pptx
ashe.s.pptxashe.s.pptx
ashe.s.pptx
 
Identification of patients with dermatophytes
Identification of patients with dermatophytes Identification of patients with dermatophytes
Identification of patients with dermatophytes
 
Dermatophyte,_candida_and_aspergillosis.pdf
Dermatophyte,_candida_and_aspergillosis.pdfDermatophyte,_candida_and_aspergillosis.pdf
Dermatophyte,_candida_and_aspergillosis.pdf
 
Fungal infection of skin (Dermatophytosis , yeast infection)
Fungal infection of skin (Dermatophytosis , yeast infection)Fungal infection of skin (Dermatophytosis , yeast infection)
Fungal infection of skin (Dermatophytosis , yeast infection)
 
anti fungal.pptx
anti fungal.pptxanti fungal.pptx
anti fungal.pptx
 
Dermatology 5th year, 5th lecture (Dr. Darseem)
Dermatology 5th year, 5th lecture (Dr. Darseem)Dermatology 5th year, 5th lecture (Dr. Darseem)
Dermatology 5th year, 5th lecture (Dr. Darseem)
 
5. dermatological infections
5. dermatological infections5. dermatological infections
5. dermatological infections
 
FUNGAL.pptx
FUNGAL.pptxFUNGAL.pptx
FUNGAL.pptx
 
dermatological infections.pptx
dermatological infections.pptxdermatological infections.pptx
dermatological infections.pptx
 
Skin fungal infection
Skin fungal infectionSkin fungal infection
Skin fungal infection
 
Dermatophyte infection (2).pptx
Dermatophyte infection (2).pptxDermatophyte infection (2).pptx
Dermatophyte infection (2).pptx
 
Antifungals
AntifungalsAntifungals
Antifungals
 
Dermatophytes .pptx
Dermatophytes .pptxDermatophytes .pptx
Dermatophytes .pptx
 
Superficial fungal infections
Superficial fungal infectionsSuperficial fungal infections
Superficial fungal infections
 
Fungal Infections.pptx
Fungal Infections.pptxFungal Infections.pptx
Fungal Infections.pptx
 
Superficial fungal skin infections.ppt
Superficial fungal skin infections.pptSuperficial fungal skin infections.ppt
Superficial fungal skin infections.ppt
 
Fungal infections
Fungal infectionsFungal infections
Fungal infections
 
Common Dermatological Problems
Common Dermatological ProblemsCommon Dermatological Problems
Common Dermatological Problems
 
ppt_by_NA_.pptx
ppt_by_NA_.pptxppt_by_NA_.pptx
ppt_by_NA_.pptx
 

Slides on fungal disease 2

  • 1. ANTIFUNGAL THERAPY Tinea Infection Treatment By SUDIPTO HALDAR
  • 2. Cause Of Fungal Infection Superficial Fungal Infections may be caused by different types of Fungi, like -  Dermatophytes  Molds  Yeasts The most common fungal infections are caused by the Dermatophytes, which are the most abundant in their distribution Such infections are commonly termed as TINEA Infections
  • 3. Tinea Infection: The common TINEA Infections are : Tinea corporis Tinea cruris Tinea pedis Tinea capitis Tinea versicolor Tinea unguium (Onychomycosis caused by dermatophytes) Common Superficial infections caused by oher species include Onychomycosis (caused by Candida) Cutaneous candidiasis
  • 4. Tinea Corporis  Cause: Tinea corporis is a common skin disorder among children. However, it may occur in people of all ages. It is caused by mold-like fungi called dermatophytes.  Fungi thrive in warm, moist areas. The following raise your risk for a fungal infection:  Long-term wetness of the skin (such as from sweating)  Minor skin and nail injuries  Poor hygiene  Tinea corporis can spread easily to other people. You can catch the condition if you come into direct contact with an area of ringworm on someone's body, or if you touch contaminated items such as:  Clothing  Combs  Pool surfaces  Shower floors and walls  The fungi can also be spread by pets (cats are common carriers).
  • 5. Tinea Corporis Symptoms Symptoms may include itching.  The rash begins as a small area of red, raised spots and pimples. The rash slowly becomes ring-shaped, with a red- colored, raised border and a clearer center. The border may look scaly.  The rash may occur on the arms, legs, face, or other exposed body areas.
  • 6. Tinea Corporis Signs and tests  The health care provider can often diagnose tinea corporis by how the skin looks.  In some cases, the following tests may be done:  Looking at a skin scraping of the rash under the microscope using a KOH (potassium hydroxide) test  Skin lesion biopsy
  • 7. Treatment  TOPICAL THERAPY: Topical therapy should be applied to the lesion and at least 2 cm beyond this area once or twice a day for at least 2 weeks, depending on which agent is used. Topical azoles and allylamines show high rates of clinical efficacy. These agents inhibit the synthesis of ergosterol, a major fungal cell membrane sterol.  SYSTEMIC THERAPY: Systemic therapy may be indicated for tinea corporis that includes extensive skin infection, immunosuppression, resistance to topical antifungal therapy. Use of oral agents requires attention to potential drug interactions and monitoring for adverse effects.
  • 8. Tinea Cruris  Tinea cruris, a pruritic superficial fungal infection of the groin and adjacent skin, is the second most common clinical presentation for dermatophytosis. Tinea cruris is a common and important clinical problem that may, at times, be a diagnostic and therapeutic challenge.
  • 9. PATHOPHYSIOLOGY  The most common etiologic agents for tinea cruris include Trichophyton rubrum and Epidermophyton floccosum; less commonly Trichophyton mentagrophytes and Trichophyton verrucosum are involved.  Tinea cruris is a contagious infection transmitted by fomites, such as contaminated towels or hotel bedroom sheets, or by autoinoculation from a reservoir on the hands or feet (tinea manuum, tinea pedis, tinea unguium).  The etiologic agents in tinea cruris produce keratinases, which allow invasion of the cornified cell layer of the epidermis. The host immune response may prevent deeper invasion. Risk factors for initial tinea cruris infection or reinfection include wearing tight-fitting or wet clothing or undergarments.
  • 10. Tinea Cruris Treatment  Clinical cure of an uncomplicated tinea cruris infection usually can be achieved using topical antifungal agents of the imidazole or allylamine family. Consider patients unable to use topical treatments consistently or with extensive or recalcitrant infection as candidates for systemic administration of antifungal therapy, which has been proven safe in immunocompetent persons.  Prevention of tinea cruris reinfection is an essential component of disease management. Patients with tinea cruris often have concurrent dermatophyte infections of the feet and hands.  Treat all active areas of tinea cruris infection simultaneously to prevent reinfection of the groin from other body sites.  Advise patients with tinea pedis to put on their socks before their undershorts to reduce the possibility of direct contamination.  Advise patients with tinea cruris to dry the crural folds completely after bathing and to use separate towels for drying the groin and other parts of the body.
  • 11. Tinea Pedis Tinea pedis is the term used for a dermatophyte infection of the soles of the feet and the interdigital spaces. Tinea pedis is most commonly caused byTrichophyton rubrum, a dermatophyte initially endemic only to a small region of Southeast Asia and in parts of Africa and Australia. Interestingly, tinea pedis was not noted in these areas then, possibly because these populations did not wear occlusive footwear. The colonization of the T rubrum –endemic regions by European nations helped to spread the fungus throughout Europe. Wars with accompanying mass movements of troops and refugees, the general increase in available means of travel, and the rise in the use of occlusive footwear have all combined to make T rubrum the world's most prevalent dermatophyte
  • 12. Tinea Pedis Causes:  Athlete's foot occurs when a certain fungus grows on your skin in your feet. In addition to the toes, it may also occur on the heels, palms, and between the fingers.  Athlete's foot is the most common type of tinea fungal infections. The fungus thrives in warm, moist areas. Your risk for getting athlete's foot increases if you:  Wear closed shoes, especially if they are plastic-lined  Keep your feet wet for prolonged periods of time  Sweat a lot  Develop a minor skin or nail injury  Athlete's foot is contagious, and can be passed through direct contact, or contact with items such as shoes, stockings, and shower or pool surfaces.
  • 13. Symptoms  The most common symptom is cracked, flaking, peeling skin between the toes or side of the foot. Other symptoms can include:  Red and itchy skin  Burning or stinging pain  Blisters that ooze or get crusty  If the fungus spreads to your nails, they can become discolored, thick, and even crumble.  Athlete's foot may occur at the same time as other fungal skin infections such as ringworm or jock itch.
  • 14. Tinea Pedis Treatment  Tinea pedis can be treated with topical or oral antifungals or a combination of both. Topical agents are used for 1-6 weeks, depending on manufacturers' recommendations. A patient with chronic hyperkeratotic (moccasin) tinea pedis should be instructed to apply medication to the bottoms and sides of his or her feet. For interdigital tinea pedis, even though symptoms may not be present, a patient should apply the topical agent to the interdigital areas and to the soles because of the likelihood of plantar-surface infection.
  • 15. Tinea Versicolor  A fungal infection of the skin caused by Malassezia furfur and characterized by finely desquamating, pale tan patches on the upper trunk and upper arms that may itch and do not tan. In dark-skinned people the lesions may be depigmented. The fungus fluoresces under Wood's light and may be easily identified in scrapings viewed under a microscope. Topical and oral antifungal agents may be used, as well as repeated applications of selenium sulfide. The pale patches may persist for up to 1 year after successful treatment, and recurrence is common.
  • 16. Tinea Versicolor  Signs & Symptoms: Acidic bleach from the growing yeast causes areas of skin to be a different color than the skin around them. These can be individual spots or patches. Specific signs and symptoms of the infection include:  Patches that may be white, pink, red, or brown and can be lighter or darker than the skin around them.  Spots that do not tan the way the rest of your skin does.  Spots that may occur anywhere on your body but are most commonly seen on your neck, chest, back, and arms.  The spots may disappear during cool weather and get worse during warm and humid weather. They may be dry and scaly and may itch or hurt, although this is not common.
  • 17. Treatment Of Tinea Versicolor  Treatment of tinea versicolor can consist of creams, lotions, or shampoos that are put on the skin. It can also include medication given as pills. The type of treatment will depend on the size, location, and thickness of the infected area. Treatment options include:  Topical anti-fungals:These products are applied directly to your skin and may be in the form of lotions, shampoos, creams, or soaps. They keep the growth of the yeast under control. Over-the-counter anti-fungal topical products containing ingredients such as selenium sulfide, miconazole, clotrimazole, and terbinafine are available. But sometimes prescription medications may be needed.
  • 18. Treatment Of Tinea Versicolor  Anti-fungal pills: These may be used to treat more serious or recurrent cases of tinea versicolor. Or in some cases they may be used because they can provide a simpler and quicker resolution of the infection. These medicines are given by prescription and can have side effects. So it's important to be monitored by your doctor while using anti-fungal pills. Treatment usually eliminates the fungal infection. However, the discoloration of the skin may take up to several months to resolve.
  • 19. Onychomycosis  Onychomycosis is a fungal infection of the toenails or fingernails.  Cause: Onychomycosis causes fingernails or toenails to thicken, discolor, disfigure, and split. At first, onychomycosis appears to be only a cosmetic concern. Without treatment, however, the toenails can become so thick that they press against the inside of the shoes, causing pressure, irritation, and pain. Fingernail infection may cause psychological, social, or employment-related problems.
  • 20. Onychomycosis Symptoms & Signs  Onychomycosis usually does not cause any symptoms unless the nail becomes so thick it causes pain when wearing shoes. People with onychomycosis usually go to the doctor for cosmetic reasons, not because of physical pain or problems related to onychomycosis.  As the nail thickens, onychomycosis may interfere with standing, walking, and exercising.  Paresthesia (a sensation of pricking, tingling, or creeping on the skin having noobjective cause and usually associated with injury or irritation of a nerve), pain, discomfort, and loss of agility (dexterity) may occur. Loss of self-esteem, embarrassment, and social problems can also develop.  Severe cases of Candida infections can disfigure the fingertips and nails.
  • 21. Treatment on Onychomycosis  In the past, medicines used to treat onychomycosis (OM) were not very effective. OM is difficult to treat because nails grow slowly and receive very little blood supply. However, recent advances in treatment options, including oral (taken by mouth) and topical (applied on the skin or nail surface) medications, have been made. Newer oral medicines have revolutionized treatment of onychomycosis. However, the rate of recurrence is high, even with newer medicines. Treatment is expensive, has certain risks, and recurrence is possible.
  • 22. Dosage & Administration Of Terbinafine to Eradicate Tinea  The Oral dose of Terbinafine is a constant 250 mg O.D. in adults  The duration can vary considerably, depending on the condition (severity, area of distribution and duration of the disease)  ADULT DOSAGE  Tinea Corporis : Topical application once or twice daily, for 1 to 2 wks; Orally 250 mg O.D. for up to 4 weeks  Tinea Cruris : Topical application once or twice daily for 1 to 2 weeks; Orally 250 mg O.D. for 2 to 4 weeks  Tinea Pedis : Topical application once or twice daily for 1 week;  Orally 250 mg O.D. for up to 6 weeks  Tinea Capitis : Orally 250 mg O.D. for 4 weeks (rarely found in adults)  Tinea Versicolor : Topical application once or twice daily for 1 to 2 weeks, suitable oral antimycotic drug may be co-prescribed, like Terbinafine itself, or Fluconazole.
  • 23. Dosage & Administration Of Terbinafine  PAEDIATRIC DOSAGE  Terbinafine can be safely used in children over 1 year of age, for Tinea infections, Onychomycosis, and especially Tinea Capitis, in the following per kg body wt. dose:  10 - 20 kg - 62.5 mg O.D.  20 - 40 kg - 125 mg O.D.  >40 kg - 250 mg O.D.  The indication-wise dosage in children is as follows :  Tinea Capitis - 2 weeks to 4 weeks  Tinea Cruris - 2 to 4 weeks  Tinea Corporis - 4 weeks  Onychomycosis - Up to 6 weeks, in case of fingernail, or longer Up to 12 weeks, in case of toenail, or longer
  • 24. Adjuvant therapy with Ketoconazole in Tinea Infection 2% Ketoconazole w/w offers freedom from and protects against Tinea Versicolor, and also effective as an adjuvant therapy along with topical and oral antifungal drugs to treat tinea and candida skin infections.